Astellas Expects To Launch Bladder Drug In Japan, Europe, U.S.
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma Inc. said it expects to launch its YM178 (mirabegron) bladder drug in Japan, Europe and the United states in fiscal year 2012